Keyphrases
51Cr-EDTA
20%
99mTc-DTPA
20%
Absorbed Dose
14%
Beta Emitter
20%
Bioelectrical Impedance Analysis
20%
Body Cell Mass
80%
Body Composition
20%
Body Surface Area
15%
Bone Marrow Infection
20%
C-11
20%
Cell Membrane Capacitance
20%
Cell Membrane Integrity
20%
Child Effects
20%
Children's Body
80%
Clearance Methods
20%
Concentration Curve
13%
Creatinine
60%
Cutoff Level
20%
Cystatin C (Cys C)
70%
Estimation Accuracy
60%
Extracellular Resistance
13%
Extracellular Volume
20%
Filtration Barrier
20%
Glomerular Filtration Rate
80%
In Vivo Biodistribution
20%
In Vivo Dosimetry
20%
Kidney Filtration
20%
Limits of Agreement
15%
Long-lived Radionuclides
20%
Mass Increase
80%
Multi-tracer
20%
Multiple Injections
20%
Patlak Plot
20%
Pediatric Population
20%
PET Kinetics
20%
Pharmacokinetic Model
20%
Popliteal Lymph Node
11%
Positron Range
20%
Prediction Model
19%
Radiation Protection
20%
Radiopharmaceuticals
20%
Rate Prediction
20%
Reduced Kidney Function
20%
Renal Function
60%
Sacubitril-valsartan
20%
Serum Creatinine
29%
Siglec-9
20%
Subcutaneous Space
20%
Time-concentration Curve
20%
Transformed Data
11%
Medicine and Dentistry
Bioelectrical Impedance Analysis
43%
Body Weight
6%
Cancer Therapy
20%
Cancer Treatment
6%
Carbon 11
40%
Cell Function
13%
Cell Membrane
40%
Creatinine
48%
Cystatin C
46%
Diagnosis
8%
Diseases
40%
Donepezil
22%
Fluorodeoxyglucose F 18
42%
Gallium 68
48%
Glomerular Filtration Rate
69%
Glomerulus Filtration
24%
Hydration Status
13%
Image Quality
20%
Immunohistochemistry
20%
Immunotherapy
13%
Infection
63%
Injury
20%
Iodine 124
15%
Kidney Function
95%
Linear Regression Analysis
6%
Lymph Node
20%
Methionine
37%
Methionine C 11
11%
Nephrotic Syndrome
40%
Non Small Cell Lung Cancer
13%
Nuclear Medicine
6%
Osteomyelitis
45%
Pediatrics
20%
Pharmacokinetics
6%
Physiological Process
7%
Positron Emission Tomography
63%
Radioactive Tracer
63%
Radioisotope
15%
Renography
20%
Resistance Index
20%
Sacubitril
20%
Sacubitril Plus Valsartan
20%
Sialic Acid Binding Immunoglobulin Like Lectin
22%
Soft Tissue Infection
22%
Staphylococcus Aureus
8%
Systematic Review
20%
Technetium-99
7%
Tetraxetan
20%
Thyroid Scintiscanning
20%
Uptake Rates
8%
Pharmacology, Toxicology and Pharmaceutical Science
Biodistribution
20%
Carbon 11
20%
Chromium 51
34%
Comorbidity
20%
Creatinine
80%
Cross-Validation
11%
Cystatin C
100%
Donepezil
20%
Edetate Chromium
6%
Edetate Chromium Cr 51
6%
Elimination
10%
Ethylenediaminetetraacetic Acid
31%
Frailty
10%
Gamma Ray
6%
Hydration
13%
Hypodermoclysis
20%
Immunotherapy
13%
Iodine 124
20%
Malignant Neoplasm
20%
Methionine
20%
Methionine C 11
11%
Non Small Cell Lung Cancer
13%
Pentetic Acid
20%
Peripheral Vascular Disease
20%
Pertechnetic Acid Tc 99m
10%
Pharmacokinetics
20%
Radioisotope
40%
Retrospective Study
10%
Satoreotide Tetraxetan Lu 177
20%
Serum Albumin
11%
Sialic Acid Binding Immunoglobulin Like Lectin
20%
Sodium Chloride
10%
Subcutaneous Injection
10%
Technetium 99m
20%
Thyroiditis
10%
Thyrotropin
20%
Tracer
86%
Ureaplasma
14%
Valsartan/Sacubitril
20%
Vascular Adhesion Protein 1
10%